Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative intravenous lidocaine for inflammation and acute pain after breast cancer surgery
NL-OMON39927Phase 4Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lidocaine in postoperative pain and breast cancer (2 arms), sponsored by Radboud University Medical Center. Primary endpoints: Change in plasma cytokine levels and Change in plasma ICAM-1 levels. Started Nov 2014; status: active, not recruiting.
02
Drugs
lidocaine
03
Conditions
postoperative painbreast cancer
Beyond the preview
Go deeper on NL-OMON39927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39927.